These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Multi-state models for bone marrow transplantation studies. Klein JP; Shu Y Stat Methods Med Res; 2002 Apr; 11(2):117-39. PubMed ID: 12040693 [TBL] [Abstract][Full Text] [Related]
25. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment. Simon W; Segel GB; Lichtman MA Blood Cells Mol Dis; 2006; 37(2):116-24; discussion 125-7. PubMed ID: 16904348 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning. Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516 [TBL] [Abstract][Full Text] [Related]
27. Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Sekhri A; Liu D; Rasul M; Ahmed N; Ahmed T; Seiter K Leuk Res; 2009 Sep; 33(9):1291-3. PubMed ID: 19344950 [TBL] [Abstract][Full Text] [Related]
28. tdc.msm: an R library for the analysis of multi-state survival data. Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136 [TBL] [Abstract][Full Text] [Related]
29. A joint frailty model for survival and gap times between recurrent events. Huang X; Liu L Biometrics; 2007 Jun; 63(2):389-97. PubMed ID: 17688491 [TBL] [Abstract][Full Text] [Related]
30. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation]. Lin Q; Dong M; Wang QM; Wen JY; Wu XY Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772 [TBL] [Abstract][Full Text] [Related]
32. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes. Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248 [TBL] [Abstract][Full Text] [Related]
33. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report. Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949 [No Abstract] [Full Text] [Related]
34. Nested frailty models using maximum penalized likelihood estimation. Rondeau V; Filleul L; Joly P Stat Med; 2006 Dec; 25(23):4036-52. PubMed ID: 16463308 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D; Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723 [TBL] [Abstract][Full Text] [Related]
36. Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation. Ritchie DS; Sainani A; D'Souza A; Grigg AP Am J Hematol; 2005 Aug; 79(4):299-302. PubMed ID: 16044450 [TBL] [Abstract][Full Text] [Related]
37. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665 [TBL] [Abstract][Full Text] [Related]
38. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A; Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791 [TBL] [Abstract][Full Text] [Related]
39. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia. Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976 [TBL] [Abstract][Full Text] [Related]
40. Post-transplantation dynamics of the immune response to chronic myelogenous leukemia. DeConde R; Kim PS; Levy D; Lee PP J Theor Biol; 2005 Sep; 236(1):39-59. PubMed ID: 15967182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]